BI 695501 Versus Humira in Patients With Active Crohn's Disease: a Trial Comparing Efficacy, Endoscopic Improvement, Safety, and Immunogenicity

NCT02871635 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

147

Enrollment

INDUSTRY

Sponsor class

Conditions

Crohn Disease

Interventions

DRUG: BI 695501
DRUG: HUMIRA

Sponsor

Boehringer Ingelheim